| 来源类型 | Working Paper
|
| 规范类型 | 报告
|
| DOI | 10.3386/w23900
|
| 来源ID | Working Paper 23900
|
| Measuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments |
| Kristopher J. Hult
|
| 发表日期 | 2017-10-09
|
| 出版年 | 2017
|
| 语种 | 英语
|
| 摘要 | Individuals respond to pharmaceutical treatments differently due to the heterogeneity of patient populations. This heterogeneity can make it difficult to determine how efficacious or burdensome a treatment is for an individual patient. Personalized medicine involves using patient characteristics, therapeutics, or diagnostic testing to understand how individual patients respond to a given treatment. Personalized medicine increases the health impact of existing treatments by improving the matching process between patients and treatments and by improving a patient's understanding of the risk of serious side effects. In this paper, I compare the health impact of new treatment innovations with the potential health impact of personalized medicine. I find that the impact of personalized medicine depends on the number of treatments, the correlation between treatment effects, and the amount of noise in a patient's individual treatment effect signal. For multiple sclerosis treatments, I find that personalized medicine has the potential to increase the health impact of existing treatments by roughly 50 percent by informing patients of their individual treatment effect and risk of serious side effects. |
| 主题 | Health, Education, and Welfare
; Health
; Development and Growth
; Innovation and R&
; D
|
| URL | https://www.nber.org/papers/w23900
|
| 来源智库 | National Bureau of Economic Research (United States)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/581573
|
推荐引用方式
GB/T 7714 |
Kristopher J. Hult. Measuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments. 2017.
|
|
文件名：
|
w23900.pdf
|
|
格式：
|
Adobe PDF
|
此文件暂不支持浏览
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
